Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Tyson

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1993
Dose-ranging evaluation of the substituted benzamide dazopride when used as an antiemetic in patients receiving anticancer chemotherapyS C Grant, M G Kris, R J Gralla, et al.
Cancer|January 1, 1993
Dose-ranging antiemetic evaluation of the serotonin antagonist tropisetron in patients receiving anti-cancer chemotherapyK M Pisters, M G Kris, L B Tyson, et al.
American Journal of Clinical Oncology|June 1, 1989
Dose-ranging antiemetic trial of high-dose oral metoclopramideL B Tyson, R J Gralla, M G Kris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatinM G Kris, R J Gralla, L B Tyson, et al.
Cancer|November 1, 1993
Dose-ranging antiemetic evaluation of the serotonin antagonist RG 12915 in patients receiving anticancer chemotherapyL Baltzer, M G Kris, L B Tyson, et al.
American Journal of Clinical Oncology|June 1, 1994
Randomized phase II trial comparing two versus three doses of ondansetron when used in combination with dexamethasone in patients receiving cisplatin > or = 100 mg/m2L B Tyson, M G Kris, L Baltzer, et al.
American Journal of Clinical Oncology|December 1, 1985
Phase 1 trial of levonantradol in chemotherapy-induced emesisL B Tyson, R J Gralla, R A Clark, et al.
American Journal of Clinical Oncology|February 1, 1993
Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2M G Kris, R A Clark, L B Tyson, et al.
Cancer|September 1, 1995
Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicinL B Cleri, M G Kris, L B Tyson, et al.
Cancer|November 15, 1996
Are more antiemetic trials with a placebo necessary? Report of patient data from randomized trials of placebo antiemetics with cisplatinM G Kris, L X Cubeddu, R J Gralla, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|January 1, 1993
Dose-ranging evaluation of the substituted benzamide dazopride when used as an antiemetic in patients receiving anticancer chemotherapyS C Grant, M G Kris, R J Gralla, et al.
Cancer|January 1, 1993
Dose-ranging antiemetic evaluation of the serotonin antagonist tropisetron in patients receiving anti-cancer chemotherapyK M Pisters, M G Kris, L B Tyson, et al.
American Journal of Clinical Oncology|June 1, 1989
Dose-ranging antiemetic trial of high-dose oral metoclopramideL B Tyson, R J Gralla, M G Kris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatinM G Kris, R J Gralla, L B Tyson, et al.
Cancer|November 1, 1993
Dose-ranging antiemetic evaluation of the serotonin antagonist RG 12915 in patients receiving anticancer chemotherapyL Baltzer, M G Kris, L B Tyson, et al.
American Journal of Clinical Oncology|June 1, 1994
Randomized phase II trial comparing two versus three doses of ondansetron when used in combination with dexamethasone in patients receiving cisplatin > or = 100 mg/m2L B Tyson, M G Kris, L Baltzer, et al.
American Journal of Clinical Oncology|December 1, 1985
Phase 1 trial of levonantradol in chemotherapy-induced emesisL B Tyson, R J Gralla, R A Clark, et al.
American Journal of Clinical Oncology|February 1, 1993
Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2M G Kris, R A Clark, L B Tyson, et al.
Cancer|September 1, 1995
Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicinL B Cleri, M G Kris, L B Tyson, et al.
Cancer|November 15, 1996
Are more antiemetic trials with a placebo necessary? Report of patient data from randomized trials of placebo antiemetics with cisplatinM G Kris, L X Cubeddu, R J Gralla, et al.
Pageof 3